How the Karnataka High Court’s Stay of the FSSAI Advisory Raises Questions of Administrative Authority and Judicial Review over Ashwagandha Use in Supplements

The Karnataka High Court, exercising its supervisory jurisdiction over administrative actions, issued an order that temporarily halted the implementation of an advisory released by the Food Safety and Standards Authority of India, which had sought to prohibit or limit the inclusion of the botanical ingredient known as Ashwagandha leaves in products classified as health supplements, thereby affecting manufacturers, distributors, and consumers who rely on such herbal formulations within the territorial jurisdiction of the court. The advisory, described as a regulatory guidance aimed at safeguarding public health by restricting a specific plant part traditionally used in Ayurvedic preparations, carried significant persuasive authority for industry stakeholders seeking compliance with food safety norms, and its anticipated effect on the market for herbal health products prompted the court’s intervention to preserve the status quo pending further judicial consideration. By granting a stay, the high court signalled that the advisory’s enforceability and its impact on commercial interests warranted a careful examination of the legal foundations underlying the food authority’s power to restrict ingredients without a formal rulemaking process, thus ensuring that any limitation on trade or consumer choice adheres to principles of reasoned decision-making and procedural fairness recognized under Indian administrative law.

One question is whether the Food Safety and Standards Authority of India possesses the statutory authority to issue an advisory that effectively bans or restricts the use of a specific botanical ingredient in health supplements without first conducting a formal rulemaking procedure mandated by the Food Safety and Standards Act. The answer may depend on the interpretation of the authority’s delegated powers under the act, particularly whether an advisory can be treated as a binding regulation for compliance purposes, and whether the absence of a published draft, opportunity for public comment, and documented rationale would violate the procedural requirements embedded in principles of natural justice.

Perhaps the more important legal issue is the scope of the Karnataka High Court’s power to stay such an advisory, wherein the court must balance its duty to protect lawful commercial activity against the need to ensure that public-health measures are not implemented arbitrarily, and the appropriate standard of review—whether it be a question of law, a question of fact, or a hybrid approach—will shape the degree of deference afforded to the regulator’s expertise. Perhaps the procedural significance lies in whether the stay reflects a prima facie finding that the advisory may be ultra vires, lacking a clear statutory basis, or that its implementation would cause disproportionate hardship to businesses relative to the alleged health benefits, thereby invoking the proportionality test rooted in constitutional jurisprudence.

Perhaps a competing view may argue that the advisory, even if issued as guidance, carries sufficient weight to be treated as an interim restriction under the precautionary principle, and that the high court’s stay should be limited to preserving the status quo only until the authority provides a detailed scientific justification and complies with the procedural safeguards envisaged by the administrative law framework. A fuller legal conclusion would require clarity on whether the advisory’s language explicitly mandates cessation of the ingredient’s use, or merely recommends voluntary avoidance, because the distinction influences the degree of enforceability and the necessity for judicial oversight under the doctrine of administrative discretion.

If later facts show that the Food Safety and Standards Authority of India possesses a robust evidential basis linking Ashwagandha leaf consumption to specific health risks, the question may become whether the regulator could have pursued a formal amendment to the relevant standards, and whether the high court’s stay should be lifted in light of compelling scientific data that satisfies the burden of proof required for imposing market-wide restrictions. The safer legal view would depend upon whether the regulator, after furnishing a comprehensive risk assessment report, seeks to formalize the restriction through an amendment to the standards, thereby providing a clearer statutory footing and enabling affected parties to challenge the measure through established avenues of administrative review.

Thus, the Karnataka High Court’s interim relief not only underscores the delicate balance between public health objectives and commercial freedoms but also highlights the necessity for regulatory agencies to adhere strictly to procedural requirements when issuing advisories that may function as de facto restrictions, ensuring that future disputes can be resolved within a transparent legal framework that respects both consumer safety and the rule of law.